Table 57.
Reported human cases of congenital toxoplasmosis and notification rates per 100,000 live births in the EU/EFTA, by country and year, 2013–2017
| Country | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National coveragea | Data formata | Total cases | Confirmed cases & rates | Confirmed cases & rates | Confirmed cases & rates | Confirmed cases & rates | Confirmed cases & rates | ||||||
| Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | ||||
| Austria | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Belgium | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Bulgaria | Y | A | 2 | 2 | 3.08 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Croatia | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Cyprus | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Czech Republic | Y | C | 2 | 2 | 1.78 | 0 | 0.00 | 1 | 0.90 | 1 | 0.90 | 0 | 0.00 |
| Denmark | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Estonia | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Finland | Y | C | 0 | 0 | 0.00 | 1 | 1.80 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Franceb | Y | C | – | – | – | 195 | 24.9 | 246 | 30.8 | 216 | 26.4 | 179 | 22.0 |
| Germany | Y | C | 6 | 6 | 0.76 | 10 | 1.36 | 15 | 2.03 | 6 | 0.80 | 10 | 1.50 |
| Greece | – | – | 0 | – | 0.00 | – | – | – | – | – | – | – | – |
| Hungary | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 1 | 1.10 | 3 | 3.20 | 0 | 0.00 |
| Ireland | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 1 | 1.50 | 0 | 0.00 | 1 | 1.50 |
| Italy | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Latvia | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Lithuania | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 1 | 3.30 | 0 | 0.00 | 1 | 3.30 |
| Luxembourg | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Malta | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Netherlands | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Poland | Y | C | 18 | 18 | 4.71 | 20 | 5.42 | 15 | 4.00 | 20 | 5.30 | 18 | 4.90 |
| Portugal | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Romania | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 1 | 0.50 | 0 | 0.00 |
| Slovakia | Y | C | 0 | 0 | 0.00 | 2 | 3.60 | 0 | 0.00 | 0 | 0.00 | 2 | 3.60 |
| Slovenia | Y | C | 2 | 2 | 9.83 | 1 | 4.84 | 1 | 4.80 | 0 | 0.00 | 0 | 0.00 |
| Spainc | N | C | 3 | 3 | – | 5 | – | 0 | – | 0 | – | 0 | – |
| Sweden | – | – | – | – | – | – | – | – | – | – | – | – | – |
| United Kingdom | Y | C | 7 | 7 | 0.90 | 8 | 1.03 | 7 | 0.90 | 11 | 1.40 | 2 | 0.30 |
| EU Total | – | – | 40 | 40 | 1.31 | 242 | 6.72 | 288 | 8.27 | 258 | 7.40 | 213 | 6.20 |
| Iceland | Y | C | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
| Norway | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Switzerlandd | – | – | – | – | – | – | – | – | – | – | – | – | – |
a
Y: yes; N: no; A: aggregated data; C: case‐based data; –: no report.
b
France: 2017 data not reported as there is a 2‐year delay in reporting of congenital toxoplasmosis in France.
c
Sentinel surveillance; no information on estimated coverage. So, notification rate cannot be estimated.
d
Switzerland provided data directly to EFSA. The human data for Switzerland include data from Liechtenstein.